Author

Johana Tournois

InsermORCID 0000-0003-0696-1307Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anca Marian· 1 shared Anne BigotiD· 1 shared Anne BolandiD· 1 shared Anthony Brureau· 1 shared Cécile MartinatiD· 1 shared Céline BrugeiD· 1 shared Christophe BattailiD· 1 shared Didier AuboeufiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Anca Marian

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyBritish Journal of PharmacologyPeer-reviewedMar 19, 2025

Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screening.

Céline Bruge, Nathalie Bourg, Emilie Pellier…·Xavier Nissan

This study identifies bazedoxifene as a potential treatment for LGMD R2 through high-throughput screening of drugs targeting dysferlin aggregation.

3 citations

mouseproteomics

𝕏 PostBluesky

GenomicsbioRxivPreprintFeb 4, 2025

Integrative Analysis of Drug-Gene Expression Signatures in Human Pluripotent Stem Cells Identifies Novel Drug Candidates for ALS and Monogenic Diseases

Florine Roussange, Jacqueline Gide, Johana Tournois…·Sandrine Baghdoyan

The paper identifies novel drug candidates for ALS and monogenic diseases by analyzing drug-induced gene expression changes in human pluripotent stem cells using RNA sequencing.

DOI 10.1101/2025.02.04.636445

humanbulk RNA-seq

𝕏 PostBluesky